Literature DB >> 10910022

Therapeutic apheresis application using membrane plasma fractionation technology: present scope and limitations.

A Sueoka1.   

Abstract

Membrane technologies have been applied for therapeutic apheresis, such as plasma separation and plasma fractionation. Membrane used for plasma fractionation has a microporous structure with pore sizes in the range of 0.01-0.04 microm. A membrane plasma fractionator is utilized for the second filter in the double filtration plasmapheresis (DFPP) system and is applied for treatment of various diseases. This article summarizes the present scope and limitation of membrane plasma fractionation.

Mesh：

Substances：

Year:  2000        PMID： 10910022     DOI： 10.1046/j.1526-0968.2000.00218.x

Source DB:  PubMed          Journal:  Ther Apher        ISSN： 1091-6660


  3 in total

1.  Plasmapheresis in a patient with antiphospholipid syndrome before living-donor kidney transplantation: a case report.

Authors:  Tadashi Sofue; Yushi Hayashida; Taiga Hara; Kazuyo Kawakami; Nobufumi Ueda; Yoshio Kushida; Masashi Inui; Hiroaki Dobashi; Yoshiyuki Kakehi; Masakazu Kohno
Journal:  BMC Nephrol       Date:  2014-10-15       Impact factor: 2.388

2.  Cascade plasmapheresis (CP) as a preconditioning regime in ABO-incompatible live related donor liver transplants (ABOi-LDLT).

Authors:  Aseem Kumar Tiwari; Prashant Pandey; Geet Aggarwal; Ravi C Dara; Ganesh Rawat; Vimarsh Raina; Arvinder Singh Soin
Journal:  Transplant Res       Date:  2014-09-12

3.  Anti-MuSK Antibody-positive Myasthenia Gravis Successfully Treated with Outpatient Periodic Weekly Blood Purification Therapy.

Authors:  Kentaro Deguchi; Kosuke Matsuzono; Yumiko Nakano; Syoichiro Kono; Kota Sato; Shoko Deguchi; Katsuyuki Tanabe; Nozomi Hishikawa; Yasuyuki Ota; Toru Yamashita; Kiyoe Ohta; Masakatsu Motomura; Koji Abe
Journal:  Intern Med       Date:  2018-01-11       Impact factor: 1.271
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.